Top 5 Financial Stocks To Own Right Now

The broader indices are trading on a negative note this Friday afternoon with the Nifty down 26 points at 10,781 and the Sensex is trading lower by 94 points at 35,505.

Nifty pharma continues to rally led by Dr Redddy’s Labs, Cipla, Glenmark Pharma, Sun Pharma and Lupin.

Nifty IT was trading in the green, as stocks like Tech Mahindra, Tata Consultancy Services, Oracle Financial and Tata Elxsi traded higher.

Bank Nifty was weak in the afternoon trade as Axis Bank, Yes Bank, Bank of Baroda, PNB, Federal Bank and State Bank of India traded lower.

related news BL Kashyap & Sons rises nearly 4% on orders win worth Rs 694 crore Ceat gains 1%; Edelweiss maintains buy, EPS to grow at CAGR of 31%

Among the oil & gas names heavy weight Reliance Industries is the only stock in green while ONGC, HPCL and IOC shed half a percent in the afternoon trade.

Top 5 Financial Stocks To Own Right Now: ProAssurance Corporation(PRA)

Advisors’ Opinion:

  • [By Shane Hupp]

    ProAssurance Co. (NYSE:PRA) – Equities research analysts at SunTrust Banks lowered their Q4 2018 earnings estimates for ProAssurance in a research report issued to clients and investors on Tuesday, February 5th. SunTrust Banks analyst M. Hughes now expects that the insurance provider will earn $0.17 per share for the quarter, down from their prior forecast of $0.33. SunTrust Banks has a “Hold” rating and a $45.00 price objective on the stock.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ProAssurance (PRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ProChain (CURRENCY:PRA) traded up 1.1% against the US dollar during the 1 day period ending at 12:00 PM ET on September 28th. ProChain has a total market cap of $5.06 million and $110,631.00 worth of ProChain was traded on exchanges in the last day. In the last seven days, ProChain has traded down 20% against the US dollar. One ProChain token can now be bought for approximately $0.10 or 0.00001535 BTC on popular exchanges including Bit-Z, FCoin, OKEx and Bibox.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on ProAssurance (PRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ProAssurance (PRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Financial Stocks To Own Right Now: Petroleum Resources Corporation(PEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Adams Natural Resources Fund (NYSE:PEO) has trended somewhat negative recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Adams Natural Resources Fund earned a coverage optimism score of -0.09 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.0521373671292 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 5 Financial Stocks To Own Right Now: Old National Bancorp Capital Trust I(ONB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Old National Bancorp (NASDAQ:ONB) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Friday.

  • [By Max Byerly]

    Russell Investments Group Ltd. reduced its holdings in shares of Old National Bancorp (NASDAQ:ONB) by 31.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 441,479 shares of the bank’s stock after selling 198,314 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.29% of Old National Bancorp worth $7,461,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Old National Bancorp (NASDAQ:ONB) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Thursday.

  • [By Ethan Ryder]

    Old National Bancorp (NASDAQ:ONB) Director Katherine E. White sold 1,064 shares of the company’s stock in a transaction dated Wednesday, May 16th. The shares were sold at an average price of $17.80, for a total transaction of $18,939.20. Following the transaction, the director now owns 1,243 shares in the company, valued at approximately $22,125.40. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Joseph Griffin]

    MetLife Investment Advisors LLC reduced its position in shares of Old National Bancorp (NASDAQ:ONB) by 9.1% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 59,196 shares of the bank’s stock after selling 5,905 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Old National Bancorp were worth $1,000,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Peregrine Capital Management LLC decreased its position in shares of Old National Bancorp (NASDAQ:ONB) by 18.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 304,956 shares of the bank’s stock after selling 69,410 shares during the period. Peregrine Capital Management LLC owned approximately 0.20% of Old National Bancorp worth $5,672,000 at the end of the most recent reporting period.

Top 5 Financial Stocks To Own Right Now: 1st Source Corporation(SRCE)

Advisors’ Opinion:

  • [By ]

    Currently, I like People’s Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on 1st Source (SRCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    1st Source Co. (NASDAQ:SRCE) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $55.00.

  • [By Stephan Byrd]

    1st Source (NASDAQ:SRCE) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Thursday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on 1st Source (SRCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    1st Source (NASDAQ:SRCE)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $56.13 and last traded at $55.94, with a volume of 100 shares changing hands. The stock had previously closed at $55.94.

Top 5 Financial Stocks To Own Right Now: eHealth Inc.(EHTH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of eHealth (NASDAQ:EHTH) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    A number of other research firms have also recently issued reports on EHTH. ValuEngine raised shares of eHealth from a sell rating to a hold rating in a research note on Wednesday, May 2nd. Cantor Fitzgerald lifted their price target on shares of eHealth to $22.00 and gave the company an overweight rating in a research note on Friday, May 18th. Zacks Investment Research cut shares of eHealth from a buy rating to a hold rating in a research note on Tuesday, May 15th. Finally, TheStreet raised shares of eHealth from a d rating to a c- rating in a research note on Thursday, April 26th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $24.00.

  • [By Logan Wallace]

    Los Angeles Capital Management & Equity Research Inc. boosted its stake in eHealth, Inc. (NASDAQ:EHTH) by 61.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,655 shares of the financial services provider’s stock after acquiring an additional 8,630 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.12% of eHealth worth $501,000 as of its most recent SEC filing.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Lisa Levin]

    Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 19 percent to $19.04 as the company posted upbeat Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 17 percent to $301.12 following strong quarterly results.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on eHealth (EHTH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 16 percent to $18.64 as the company posted upbeat Q1 results.

    Enova International, Inc. (NYSE: ENVA) shares were also up, gaining 25 percent to $28.35 following Q1 results.

Leave a Reply

Your email address will not be published. Required fields are marked *